|
1
|
Stelljes M, Beelen DW, Braess J, Sauerland
MC, Heinecke A, Berning B, Kolb HJ, Holler E, Schwerdtfeger R,
Arnold R, et al: Allogeneic transplantation as post-remission
therapy for cytogenetically high-risk acute myeloid leukemia:
Landmark analysis from a single prospective multicenter trial.
Haematologica. 96:972–979. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Medeiros BC, Othus M, Estey EH, Fang M and
Appelbaum FR: Impact of body-mass index on the outcome of adult
patients with acute myeloid leukemia. Haematologica. 97:1401–1404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsai RJ, Luckhaupt SE, Schumacher P, Cress
RD, Deapen DM and Calvert GM: Acute myeloid leukemia risk by
industry and occupation. Leuk Lymphoma. 55:2584–2591. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang ML and Bailey NG: Acute myeloid
leukemia genetics: Risk stratification and implications. Arch
Pathol Lab Med. 139:1215–1223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Papaemmanuil E, Gerstung M, Bullinger L,
Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F,
Bolli N, et al: Genomic classification and prognosis in acute
myeloid leukemia. N Engl J Med. 374:2209–2221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
The Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shlush LI, Zandi S, Mitchell A, Chen WC,
Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW,
et al: Identification of pre-leukaemic haematopoietic stem cells in
acute leukaemia. Nature. 506:328–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ritchie DS, Neeson PJ, Khot A, Peinert S,
Tai T, Tainton K, Chen K, Shin M, Wall DM, Hönemann D, et al:
Persistence and efficacy of second generation CAR T cell against
the LeY antigen in acute myeloid leukemia. Mol Ther. 21:2122–2129.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding G, Zhang Z, Chopp M, Li L, Zhang L,
Li Q, Wei M and Jiang Q: MRI evaluation of BBB disruption after
adjuvant AcSDKP treatment of stroke with tPA in rat. Neuroscience.
271:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang WQ, Wang BH and Wang QR: Thymosin
beta4 and AcSDKP inhibit the proliferation of HL-60 cells and
induce their differentiation and apoptosis. Cell Biol Int.
30:514–520. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu JM, Lawrence F, Kovacevic M, Bignon J,
Papadimitriou E, Lallemand JY, Katsoris P, Potier P, Fromes Y and
Wdzieczak-Bakala J: The tetrapeptide AcSDKP, an inhibitor of
primitive hematopoietic cell proliferation, induces angiogenesis in
vitro and in vivo. Blood. 101:3014–3020. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu H, Yang F, Sun Y, Yuan Y, Cheng H, Wei
Z, Li S, Cheng T, Brann D and Wang R: A new antifibrotic target of
Ac-SDKP: Inhibition of myofibroblast differentiation in rat lung
with silicosis. PloS One. 7:e403012012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kusinski M, Wdzieczak-Bakala J, Liu JM,
Bignon J and Kuzdak K: Acsdkp: A new potential marker of malignancy
of the thyroid gland. Langenbecks Arch Surg. 391:9–12. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu JM, Garcia-Alvarez MC, Bignon J,
Kusinski M, Kuzdak K, Riches A and Wdzieczak-Bakala J:
Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro
derived from thymosin beta4 in neoplastic diseases. Ann N Y Acad
Sci. 1194:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu JM, Kusinski M, Ilic V, Bignon J,
Hajem N, Komorowski J, Kuzdak K, Stepien H and Wdzieczak-Bakala J:
Overexpression of the angiogenic tetrapeptide acsdkp in human
malignant tumors. Anticancer Res. 28:2813–2817. 2008.PubMed/NCBI
|
|
19
|
Liozon E, Volkov L, Comte L, Trimoreau F,
Pradelles P, Bordessoule D, Frindel E and Praloran V: Acsdkp serum
concentrations vary during chemotherapy in patients with acute
myeloid leukaemia. Br J Haematol. 89:917–920. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu P, Li B, Zhang W, Li Y, Li G, Jiang X,
Wdzieczak-Bakala J and Liu J: AcSDKP regulates cell proliferation
through the PI3KCA/Akt signaling pathway. PloS One. 8:e793212013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vardiman JW, Harris NL and Brunning RD:
The World Health Organization (WHO) classification of the myeloid
neoplasms. Blood. 100:2292–2302. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Drexler HG: Classification of acute
myeloid leukemias-a comparison of FAB and immunophenotyping.
Leukemia. 1:697–705. 1987.PubMed/NCBI
|
|
23
|
Lv H, Che T, Tang X, Liu L and Cheng J:
Puerarin enhances proliferation and osteoblastic differentiation of
human bone marrow stromal cells via a nitric oxide/cyclic guanosine
monophosphate signaling pathway. Mol Med Rep. 12:2283–2290. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Juopperi TA, Bienzle D, Bernreuter DC,
Vernau W, Thrall MA and McManus PM: Prognostic markers for myeloid
neoplasms: A comparative review of the literature and goals for
future investigation. Vet Pathol. 48:182–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cîrstea M, Coliță A, Ionescu B, Ghiaur A,
Vasilescu D, Dobrea C, Jardan C, Dragomir M, Gheorghe A, Várady Z
and Lupu AR: Therapy-related myelodysplastic syndrome after
successful treatment of acute promyelocytic leukemia: Case report
and literature review. Revista Romana De Medicina De Laborator.
25:165–179. 2017. View Article : Google Scholar
|
|
26
|
Frindel E, Masse A, Pradelles P, Volkov L
and Rigaud M: Correlation of endogenous acetyl-ser-asp-lys-pro
plasma levels in mice and the kinetics of pluripotent hemopoietic
stem cells entry into the cycle after cytosine arabinoside
treatment: Fundamental and clinical aspects. Leukemia. 6:599–601.
1992.PubMed/NCBI
|
